CrownCast
CrownCast
Podcast Description
CrownCast, Crown Bioscience's podcast aims to discuss the emerging trends,
breakthroughs, and viewpoints in oncology drug discovery, and development.
Podcast Insights
Content Themes
The podcast focuses on critical oncology topics, including drug resistance mechanisms, the impact of artificial intelligence in drug discovery, and the evolving landscape of immuno-oncology. Episodes like 'Pioneering Strategies to Unlocking the Potential of KRAS' and 'Inside Oncology Drug Development: Overcoming Resistance with Science' explore the complexities of KRAS mutations and treatment resistance, while 'Exploring Artificial Intelligence in Drug Discovery' highlights AI's transformative role in R&D processes.
CrownCast, Crown Bioscience’s podcast aims to discuss the emerging trends,
breakthroughs, and viewpoints in oncology drug discovery, and development.
As the landscape of drug discovery evolves, breakthrough technologies like organoids are gaining traction for their potential to revolutionize how new treatments are developed. In this episode of CrownCast, Jonny McMichael, Vice President at Crown Bioscience, and Leo Price, a member of Crown Bioscience’s Scientific Advisory Board, shed light on organoids’ growing role in drug development. With insights into their application, this commentary delves into a technology that offers a significant leap toward personalized medicine, ushering in a new era for the healthcare industry.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.